This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration. This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration.

Canavan Disease

Disease ID: disease_node_9337

Connections displayed (default: 10).
Loading graph...

DbxrefGARD:5984, MESH:D017825, MIM:271900, NCI:C84611, SNOMEDCT_US_2023_03_01:80544005, UMLS_CUI:C0206307
SubclassofDOID_0050737, DOID_10579
Data SourceDOID, MESH
SynonymsACY2 DEFICIENCY, AMINOACYLASE 2 DEFICIENCY, ASP DEFICIENCY, ASPA DEFICIENCY, ASPARTOACYLASE DEFICIENCY, CANAVAN-VAN BOGAERT-BERTRAND DISEASE, Spongy degeneration of central nervous system
Mesh IdD017825
Mesh LabelCanavan Disease
Mesh SubclassofD020279, D020271
Doid LabelCanavan disease
Doid DescriptionA leukodystrophy characterized by onset in early infancy, atonia of neck muscles, hypotonia, hyperextension of legs and flexion of arms, blindness, severe mental defect, megalocephaly, and death by 18 months on the average that has_material_basis_in homozygous or compound heterozygous mutation in ASPA gene encoding aspartoacylase on chromosome 17p13. OMIM mapping confirmed by DO. [SN].
Has Material Basis InGENO_0000148
Disease Node Iddisease_node_9337
Doid IdDOID_3613
LabelCanavan Disease